Informations générales (source: ClinicalTrials.gov)
Study of Iatrogenic Effects of Treatment for Childhood Cancer - Constitution of a Biological Samples Bank as Part of a Cohort of Patients (Cohort FCCSS)
Observational [Patient Registry]
Gustave Roussy, Cancer Campus, Grand Paris (Voir sur ClinicalTrials)
décembre 2010
décembre 2017
23 juillet 2026
The constitution of a biological samples bank, attached to epidemiological studies Cohort
F-CCSS on iatrogenic effects of treatment of childhood cancer, will identify genetic
variants that can modulate the iatrogenic risks of these treatments. The main objective
is to provide a biological samples bank to consider, besides the carcinogenic risks, the
risk of other iatrogenic diseases in these children, in particular cardiac,
cerebrovascular, lung, bone and kidney. These conditions can be very incapacitating and
in some cases, fatal. Their impact, however, is poorly estimated as occurring in
adulthood, they are rarely made in relation to the treatment received in childhood. The
overall project is expected to eventually better define the iatrogenic effects prevention
strategies for cancer treatment.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT GUSTAVE ROUSSY | Carole RUBINO | 29/06/2026 07:35:04 | Contacter | ||
Critères
Tous
Inclusion Criteria:
- Patients treated for a first cancer in childhood
- Adult patients
- Signed informed consent
- Patient insured or enjoying a social security scheme
- Patients treated for a first cancer in childhood
- Adult patients
- Signed informed consent
- Patient insured or enjoying a social security scheme
- Minor patients
- Under legal protection measure patients
- Refusal of consent